Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes

This publication has 16 references indexed in Scilit:

• The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
  Nature, 2006
• Distribution of Amantadine‐Resistant H5N1 Avian Influenza Variants in Asia
  The Journal of Infectious Diseases, 2006
• Antivirals for influenza: Historical perspectives and lessons learned
  Antiviral Research, 2006
• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
  The Lancet, 2006
• Neuraminidase Inhibitor-Resistant and -Sensitive Influenza B Viruses Isolated from an Untreated Human Patient
  Antimicrobial Agents and Chemotherapy, 2006
• Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
  JAMA, 2006
• Mallards and Highly Pathogenic Avian Influenza Ancestral Viruses, Northern Europe
  Emerging Infectious Diseases, 2005
• Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
  Virus Research, 2004
• Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
  Antiviral Research, 2004
• Developing vaccines against pandemic influenza
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2001